期刊文献+

超敏C-反应蛋白检测在脑卒中的应用价值 被引量:9

The Value of hs-CRP Detection in patients with Cerebrovascular Disease
下载PDF
导出
摘要 目的探讨hs-CRP检测在脑卒中诊断和治疗中应用的价值。方法选择脑卒中病患者共68例,其中脑梗死组36例,脑出血组32例,正常对照组35例作为研究对象。hs-CRP测定采用颗粒增强免疫透射比浊法,并对hs-CRP进行统计学比较和ROC分析,分析hs-CRP与脑卒中的关系。结果脑卒中组hs-CRP水平均明显高于正常对照组(P<0.001),脑梗死组与脑出血组间比较差异无显著性(P>0.05);同时通过临床观察发现hs-CRP水平相对高者病情转归及预后差,相对低者病情转归及预后良好。相关分析结果显示,hs-CRP含量与常规检验指标(空腹血糖、甘油三酯、总胆固醇、低密度脂蛋白胆固醇)均呈显著正相关(P<0.01);与高密度脂蛋白胆固醇水平呈显著负相关(P<0.01)。结论hs-CRP水平升高与急性脑卒中患病呈显著相关,对脑卒中的诊断及预后判断具有临床价值。 Objective To discuss the content changes of high sensitive C-reactive protein (hs-CRP)and its influence on prognosis of the cerebrovascular disease. Methods hs-CRP level of 36 patients with cerebrovascular infarction and 32 patients with intracerebral hemorrhage were measured,35 cases of normal health examination were selected as a control group. Detecting the hs-CRP in CVD patients and in control group by particle-enhanced turbidimetric immunoassay(PETIA)technique,then analyzing the data with t-test and ROC curves. The correlation between hs-CRP and the cerebrovascular disease were analyzed. Results There was significant difference in the serum level of high sensitive C-reactive protein between the CVD group and the control group (P〈0.01). There was no significant difference of hs-CRP level between cerebrovascular infarction group and intracerebral hemorrhage group(P〉 0.05),and strong positive correlations were observed between the hs-CRP level and systolic pressure, the serum fasting blood glucose, total cholesterol, triglyeerides, LDL-C and HDL-C by analysis using the multivariate stepwise regression model (all P 〈0.01). Conclusion High sensitive C-reactive protein as a risk factor for CVD,and hs-CRP has a strong association with CVD, and it is regarded as an indication for the prognosis of CVD.
出处 《中国现代医生》 2008年第6期1-2,42,共3页 China Modern Doctor
关键词 脑血管疾病 脑梗死 脑出血 超敏C-反应蛋白 Cerebrovascular disease Cerebrovascular infarction Intracerebral hemorrhage High sensitive C-reactive protein
  • 相关文献

参考文献12

二级参考文献46

  • 1彭华,郭洪志.急性脑梗死及其并发多脏器功能障碍综合征患者血清C反应蛋白水平的变化[J].临床神经病学杂志,2004,17(5):330-332. 被引量:59
  • 2高建国,周农,翟金霞.血清C反应蛋白水平与脑梗死预后的关系[J].临床神经病学杂志,2005,18(1):43-44. 被引量:113
  • 3脑卒中患者临床神经功能缺损程度评分标准(1995)[J].中华神经科杂志,1996,29(6):381-383. 被引量:15750
  • 4Broderick J, Brott T, Kothari R, et al.The greater cincinnati northern kentucky stroke study: preliminary first -ever and total incidence rates of stroke among blaeks[J]. Stroke,1998,29:415 - 421.
  • 5The ancrod stroke study investigatories.Anerod for the treatment of acute ischemic brain infarction[J]. Stroke,1994,25:1755 - 1759.
  • 6National institutes of neurological disorders and stroke rt -PA stroke study group. Tissue plasminogen activator for acute ischemic stroke[J].N Eng J Med,1995,333:1581 - 1587.
  • 7Steiner T, Bluhmki E, Kaste M, et al.The ECASS 3 -hour co -hort : secondary analysis of ECASS data by time stratification, ECASS study group[J]. Cerebrovase Dis, 1998,8 : 198 - 203.
  • 8National institutes of neurological disorders and stroke rt -PA stroke study group. Generalized efficacy of t - PA for acute stroke: subgroup analysis of the NINDS t -PA stroke trial[J]. Stroke,1997,28:2119 - 2125.
  • 9National institutes of neurological disorders and stroke rt -PA stroke study group. Intracerebral hemorrhage after intravenous t -PA therapy for ischemic.stroke[J]. Stroke,1997,28:2109-2118.
  • 10Grond M, Rudolf J, Schmulling S, et al.Early intravenous thrombolysis with recombinant tissue -type plasmi-nogen activator in vertebrobasilar ischemic stroke[J]. Arch Neurol, 1998,55 : 466 - 469.

共引文献263

同被引文献92

引证文献9

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部